Comparison of Inhibitory and Bactericidal Activity of Antipseudomonal Antibiotics against Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
- 1 January 1990
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 36 (3) , 222-229
- https://doi.org/10.1159/000238770
Abstract
Using a broth microtiter dilution method, the minimum inhibitory (MIC) and minimum bactericidal concentrations (MBC) of so-called antipseudomonal antibiotics were determined against 79 Pseudomonas aeruginosa isolates from cystic fibrosis patients. On the basis of the MIC values and using DIN breakpoints, the percentual susceptibilities led to the following rank order: imipenem (91%), ciprofloxacin (90%), tobramycin (87%), amikacin (87%), ceftazidime (82%), cefsulodin (76%), piperacillin (71%), azlocillin (62%), followed by gentamicin, ceftriaxone, mezlocillin, netilmicin, and cefotaxime ( < 50%). However, evaluating MBC values according to DIN breakpoints, only ciprofloxacin (82%), tobramycin (77%), amikacin (58%), and imipenem (57%) showed a pronounced antipseudomonal effectiveness. The data indicate that MBC determinations are necessary to evaluate the antibiotic susceptibility of P. aeruginosa rather than MIC determinations, at least in patients with impaired defence mechanisms which require bactericidal therapy.Keywords
This publication has 7 references indexed in Scilit:
- Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinationsAntimicrobial Agents and Chemotherapy, 1989
- In vitro Susceptibility of Pseudomonas aeruginosa from Bacteremic and Fibrocystic Patients to Four Quinolones and Five Other Antipseudomonal AntibioticsScandinavian Journal of Infectious Diseases, 1988
- Susceptibility of 100 blood isolates of Pseudomonas aeruginosa to 19 antipseudomonal antibiotics: Old and newDiagnostic Microbiology and Infectious Disease, 1987
- In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates ofPseudomonas aeruginosaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosisAntimicrobial Agents and Chemotherapy, 1982
- Activities of New Beta-Lactam Antibiotics Against Isolates of Pseudomonas aeruginosa from Patients with Cystic FibrosisAntimicrobial Agents and Chemotherapy, 1981
- O-ANTIGEN DETERMINATION AND IDENTIFICATION OF PSEUDOMONAS-AERUGINOSA1980